Investor pressures struggling Essa to liquidate, give cash to shareholders
Essa Pharma is facing a call to wind down operations. Soleus Capital Management, one of the company’s largest shareholders, put the proposal to Essa’s board of directors after concluding that the best option is to return cash to investors.
